Drug shortages
AHA provides feedback on the Food and Drug Administration’s request for comments on the public meeting, “Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions.
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists, and Institute for Safe Medication Practices today released recommendations emerging from a recent drug shortages summit.
The National Academies of Sciences, Engineering and Medicine has released a report summarizing its Sept. 5-6 workshop on medical drug shortages during disasters and opportunities to better predict, prevent and respond to shortages.
The Food and Drug Administration will hold a public meeting Nov. 27 to receive stakeholder input on the underlying systemic causes of drug shortages and recommendations to mitigate them.
Several hospitals and health systems today officially established Civica Rx – a new not-for-profit generic drug company that will help patients by addressing shortages and high prices of lifesaving medications.
The Drug Enforcement Administration today issued its proposed 2019 aggregate production quotas for certain controlled substances, which the agency said would reduce manufacturing quotas for six frequently misused opioids by an average 10 percent.
The National Academies of Sciences, Engineering, and Medicine will host a public workshop Sept. 5-6 on “Medical Product Shortages during Disasters: Opportunities to Predict, Prevent and Respond.”
The American Society of Health-System Pharmacists this week published updated guidelines for managing drug shortages.
AHA comments on the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Food and Drug Administration Commissioner Scott Gottlieb, M.D., today announced the formation of a drug shortages task force.